Cotrimoxazole is effective as primary prophylaxis for Toxoplasmic encephalitis in HIV-infected patients: A case control study

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 5, 1997, Pages 499-502

  Weigel, Hugo M ^a   De Vries, Erwin ^a   Regez, Rosa M ^a   Henrichs, Jeanette H ^a   Ten Velden, Jos J A M ^a   Frissen, P H Jos ^a   Van Der Meer, Jan T M ^b  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PARASITE ANTIBODY; SULFONAMIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PROPHYLAXIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0030687872     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709011862     Document Type: Article

References (24)

1. Luft BJ, Remington JS. Toxoplasmic Encephalitis. J Infect Dis 1988; 157: 1-6.
2. de Gans J, Portegies P. Neurologic complications of infection with human immunodeficiency virus type 1. Clin Neurol Neurosurg 1989; 91: 199-217.
3. Renold C, Sugar A, Chave J-P, Perrin L, Delavelle J, Pizzoloti G, et al. Toxoplasma encephalitis in patients with the aquired immunodeficiency syndrome. Medicine 1992; 71: 224-39.
4. Girard P-M, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, et al. Dapsone-pyrimethamine compared with aerosolzed pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328: 1514-20.
5. Oksenhendler E, Charrreau I, Tournerie Ch, Azihary M, Carbon C, Aboulker J-P. Toxoplasmosis gondii infection in advanced HIV infection. AIDS 1994; 8: 483-7.
6. Opravil M, Hirschel B, Lazzarin A, Heald A, Pèchere M, Rüttimann S, et al. Once-weekly administration of Dapsone/ pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis 1995; 20: 531-41.
7. Falangola MF, Petite CK. Choroid plexus infection in cerebral toxoplasmosis in AIDS patients. Neurology 1993; 43: 2035-40.
8. Luft BJ, Remington JS. Toxoplasmic Encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-22.
9. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lympfocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Aquir Immune Defic Syndr 1991; 4: 770-6.
10. Leeuwen van R, Hurk van den PJ, Mulder JW, Roos MThL, Schellekens PThA, Reiss P, Lange JMA. Opportunistic disease as measure of Immunodeficiency in HIV Infection. In: Janossi GAB, Miedema F, eds. Immunodeficiency in HIV infection and AIDS. EC/FERS/MRC Workshop on Immunodeficiency in HIV-I Infections, Windsor, Surrey. 1991. Basel: Karger S. 1992, p. 54-63.
11. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the aquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1643-8.
12. Nicholas P, Pierone G, Lin J, Gertman A, Schechter C, Masci J. Trimethoprim-sulfamethoxazole in the prevention of cerebral toxoplasmosis. In: VI International Conference on AIDS, San Francisco, June 20 24: Abstract ThB482, 1990.
13. O'Farrell N, Fitt S, Bateman NT, Welch JM, Bradbeer C. Prevalence of toxoplasmosis in patients with AIDS in South London: a retrospective study. In: Abstracts of the VII International Conference on AIDS, Florence. Italy, June 16-21: Abstract WB2349, 1991.
14. Schneider MME, Hoepelman AIM, Eeftinck Schattekerk JKM, Nielsen TL, van der Graaf Y, Frissen PHJ, et al. A controlled trial of aerozolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1836-41.
15. Hardy WD, Feinberg J, Finkelstein DM, Power ME, Weili He MPH, Kaczka C, et al. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondairy prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992; 327: 1842-8.
16. Carr A, Tindall B, Brew BJ, Mariott DJ, Harkness JL, Penny R, Cooper DA. Low-dose Trimethoprim-sulfamethoxazole prophylaxis for toxoplasmosis encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106-11.
17. May Th, Beuscart C, Reynes J, Marchou B, Leclercq P, Borsa Lebas F, et al. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. J Aquir Immune Defic Syndr 1994; 7: 457-62.
18. + lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991. AIDS 1992; 6: 413-20.
19. Van Delden Ch, Gabriel V, Sudre Ph, Flepp M, Overbeck von J, Hirschel B, and the Swiss HIV Cohort Study. Reasons for failure of prevention of toxoplasma encephalitis. AIDS 1996; 10: 509-13.
20. Schellekens PThA, Roos MThL. de Wolf F, Lange JMA, Miedema F. Low T-cell responsiveness to activation via CD3/ TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-I (HIV-I)-infected men. J Clin Immun 1990; 10: 121-7.
21. Podzamczer D, Salazar A, Jiménez J, Consiglio E, Santin M, Casanova A, et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995; 122: 755-61.
22. Antinori A, Murri R, Ammassari A, De Luca A, Linzalone A, Cingolani A, et al. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS 1995; 9: 1343-50.
23. Veenstra J, Veugelers PJ, Keet IPM, Ven van der AJAM, Miedema F, Lange JMA, Coutinho RA. Rapid disease progression in human immunodeficiency virus type I-infected individuals with adverse reactions to trimethoprim-sulphamethoxazole prophylaxis. Clin Infect Dis 1997; 24: 936-41.
24. Leport C, Chêne G, Morlat P, Luft BJ, Rousseau F, Pueyo S, et al. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: A double-blind, randomized trial. J Infect Dis 1996; 173: 91-7.